Get the Stockscreener App
459.58
0.24%
-0.9844
Idexx Laboratories Inc stock is traded at $459.58, with a volume of 317.46K.
It is down -0.24% in the last 24 hours and up +7.54% over the past month.
Idexx Laboratories primarily develops, manufactures, and distributes diagnostic products, equipment, and services for pets and livestock. Its key product lines include single-use canine and feline test kits that veterinarians can employ in the office, benchtop chemistry and hematology analyzers for test-panel analysis on-site, reference lab services, and tests to detect and manage disease in livestock. The firm also offers vet practice management software and consulting services to animal hospitals. Idexx gets close to 35% of its revenue from outside the United States.
See More
Previous Close:
$460.56
Open:
$465
24h Volume:
317.46K
Relative Volume:
0.50
Market Cap:
$37.71B
Revenue:
$3.84B
Net Income/Loss:
$866.24M
P/E Ratio:
44.32
EPS:
10.37
Net Cash Flow:
$792.60M
1W Performance:
+8.86%
1M Performance:
+7.54%
6M Performance:
-1.63%
1Y Performance:
-19.72%
1-Day Range:
$457.35
$468.80
1-Week Range:
$445.00
$474.67
52-Week Range:
$398.50
$583.39
Idexx Laboratories Inc Stock (IDXX) Company Profile
Name
Idexx Laboratories Inc
Sector
Industry
Phone
(207) 556-0300
Address
ONE IDEXX DRIVE, WESTBROOK, ME
Compare IDXX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
IDXX
Idexx Laboratories Inc
|
459.77 | 37.71B | 3.84B | 866.24M | 792.60M | 10.37 |
|
TMO
Thermo Fisher Scientific Inc
|
572.06 | 219.06B | 42.88B | 6.34B | 7.27B | 16.53 |
|
DHR
Danaher Corp
|
207.73 | 151.02B | 23.88B | 3.90B | 5.30B | 5.28 |
|
A
Agilent Technologies Inc
|
145.71 | 42.12B | 6.51B | 1.29B | 1.37B | 4.42 |
|
IQV
Iqvia Holdings Inc
|
208.03 | 36.97B | 15.32B | 1.41B | 1.96B | 7.62 |
Idexx Laboratories Inc Stock (IDXX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-02-24 | Initiated | Leerink Partners | Outperform |
| Jul-25-24 | Initiated | BTIG Research | Buy |
| Jan-30-24 | Downgrade | Piper Sandler | Overweight → Neutral |
| Dec-07-23 | Initiated | Exane BNP Paribas | Outperform |
| Dec-04-23 | Upgrade | Cleveland Research | Neutral → Buy |
| Aug-02-23 | Downgrade | Atlantic Equities | Overweight → Neutral |
| Jul-25-22 | Downgrade | Stifel | Buy → Hold |
| Jul-21-22 | Upgrade | Goldman | Neutral → Buy |
| Jul-12-22 | Initiated | Piper Sandler | Overweight |
| May-05-22 | Downgrade | BofA Securities | Buy → Neutral |
| Feb-08-22 | Initiated | Atlantic Equities | Overweight |
| Nov-18-21 | Initiated | Morgan Stanley | Overweight |
| Aug-05-21 | Resumed | Credit Suisse | Outperform |
| Jul-12-21 | Downgrade | Guggenheim | Buy → Neutral |
| Feb-17-21 | Initiated | Barclays | Overweight |
| Sep-09-19 | Initiated | Goldman | Neutral |
| May-23-19 | Initiated | Guggenheim | Buy |
| Nov-02-18 | Reiterated | BofA/Merrill | Buy |
| May-07-18 | Reiterated | Stifel | Buy |
| Jan-16-18 | Initiated | Piper Jaffray | Overweight |
| Aug-23-17 | Upgrade | BofA/Merrill | Neutral → Buy |
| Jul-28-17 | Upgrade | CL King | Neutral → Buy |
| Feb-03-17 | Downgrade | Feltl & Co. | Hold → Sell |
| Sep-29-16 | Resumed | BofA/Merrill | Neutral |
| Aug-16-16 | Reiterated | Stifel | Buy |
| Aug-03-16 | Upgrade | Northcoast | Sell → Neutral |
| Jul-20-16 | Reiterated | Canaccord Genuity | Buy |
| Apr-19-16 | Reiterated | Canaccord Genuity | Buy |
| Apr-01-16 | Initiated | CL King | Neutral |
| Mar-21-16 | Reiterated | Stifel | Buy |
| Feb-04-16 | Initiated | Credit Suisse | Outperform |
| Oct-29-15 | Reiterated | Stifel | Buy |
| Aug-28-15 | Downgrade | Raymond James | Outperform → Mkt Perform |
| Aug-13-15 | Reiterated | Stifel | Buy |
| Jul-23-15 | Reiterated | Canaccord Genuity | Buy |
View All
Idexx Laboratories Inc Stock (IDXX) Latest News
Why Idexx Labs Stock Rocketed Higher This Week - The Motley Fool
IDEXX Laboratories, Inc. (NASDAQ:IDXX) Shares Sold by Mirae Asset Global Investments Co. Ltd. - MarketBeat
IDEXX Laboratories (NASDAQ:IDXX) Downgraded by StockNews.com to "Hold" - MarketBeat
IDEXX Laboratories: I See Pet Healthcare As An Interesting Market For The Future - Seeking Alpha
Leerink Partnrs Has Negative Outlook for IDXX Q1 Earnings - MarketBeat
China Universal Asset Management Co. Ltd. Lowers Stock Holdings in IDEXX Laboratories, Inc. (NASDAQ:IDXX) - MarketBeat
Weaver Capital Management LLC Makes New $261,000 Investment in IDEXX Laboratories, Inc. (NASDAQ:IDXX) - MarketBeat
Ninety One UK Ltd Acquires 21,041 Shares of IDEXX Laboratories, Inc. (NASDAQ:IDXX) - MarketBeat
IDEXX Laboratories, Inc. (NASDAQ:IDXX) Shares Purchased by Paragon Capital Management Inc. - MarketBeat
IDEXX Laboratories, Inc. : Idexx Laboratories looks set for an upward trend -February 05, 2025 at 04:26 am EST - Marketscreener.com
Idexx Laboratories looks set for an upward trend -February 05, 2025 at 04:26 am EST - Marketscreener.com
DAVENPORT & Co LLC Has $2.34 Million Position in IDEXX Laboratories, Inc. (NASDAQ:IDXX) - MarketBeat
IDEXX Laboratories (IDXX) Reports an “Amazing Quarter” – Jim Cramer Calls It a “Safety Stock” - Insider Monkey
IDEXX Laboratories' SWOT analysis: stock outlook amid vet visit trends - MSN
IDEXX Laboratories' SWOT analysis: stock outlook amid vet visit trends By Investing.com - Investing.com South Africa
IDEXX Laboratories’ SWOT analysis: stock outlook amid vet visit trends By Investing.com - Investing.com Nigeria
IDEXX Laboratories (NASDAQ:IDXX) Price Target Raised to $520.00 - MarketBeat
IDEXX Laboratories (NASDAQ:IDXX) Stock Price Expected to Rise, Bank of America Analyst Says - MarketBeat
William Blair Cuts Earnings Estimates for IDEXX Laboratories - MarketBeat
IDEXX Laboratories, Inc. (NASDAQ:IDXX) Q4 2024 Earnings Call Transcript - Insider Monkey
Barclays Adjusts Price Target on IDEXX Laboratories to $520 From $481, Maintains Overweight Rating - Marketscreener.com
abrdn plc Lowers Position in IDEXX Laboratories, Inc. (NASDAQ:IDXX) - MarketBeat
Caprock Group LLC Has $834,000 Stock Holdings in IDEXX Laboratories, Inc. (NASDAQ:IDXX) - MarketBeat
IDEXX Laboratories, Inc. (NASDAQ:IDXX) Sees Significant Growth in Short Interest - MarketBeat
IDEXX Laboratories Inc (IDXX) Q4 2024 Earnings Call Highlights: Strong Revenue Growth and ... - Yahoo Finance
IDEXX Laboratories Inc (IDXX) Q4 2024 Earnings Call Highlights: Strong Revenue Growth and ... By GuruFocus - Investing.com Canada
IDEXX Labs Q4 earnings top estimates, shares edge higher - MSN
IDEXX Laboratories Reports Strong 2024 Financial Results - TipRanks
IDEXX Laboratories Exceeds Q4 Earnings Expectations - Evrim Ağacı
IDEXX Labs Earnings Call Highlights Growth and Innovation - TipRanks
Idexx: Q4 Earnings Snapshot - mySA
Wall Street closes down, pares losses after Trump delays Mexico tariffs -February 03, 2025 at 04:38 pm EST - Marketscreener.com
Wall Street closes down, pares losses after Trump delays Mexico tariffs -February 03, 2025 at 04:00 pm EST - Marketscreener.com
Tesla and IDEXX Lead Market Cap Stock Movers on Monday - MSN
Idexx Labs Earnings: Innovation Provides Bright Prospects in Oncology for 2025 - Morningstar
IDEXX Laboratories, Inc. (NASDAQ:IDXX) Shares Sold by Swedbank AB - MarketBeat
Sector Update: Health Care -February 03, 2025 at 01:46 pm EST - Marketscreener.com
IDEXX Laboratories Shares Jump as Q4 Earnings, Revenue Beat Estimates; 2025 Outlook Issued - Marketscreener.com
Stifel Nicolaus Adjusts IDEXX Laboratories Price Target to $460 From $440, Maintains Hold Rating - Marketscreener.com
IDEXX Beats Expectations With Strong Fourth-Quarter Performance - Finimize
Idexx Soars 10.5% After Crushing Q4 Estimates -- Big Buybacks and New Cancer Test Drive 2025 Outlook - Yahoo Finance
IDEXX Q4 Earnings and Revenues Top Estimates, Stock Up in Pre-Market - MSN
IDEXX Laboratories Posts Upbeat Results, Joins Stratasys, Saia And Other Big Stocks Moving Higher On Monday - Benzinga
IDEXX Laboratories (NASDAQ:IDXX) Shares Gap Up After Better-Than-Expected Earnings - MarketBeat
IDEXX stock jumps 12% as Q4 report, outlook top Street estimates - Seeking Alpha
Why Is Pet Health Company IDEXX Laboratories Stock Trading Higher On Monday? - Benzinga
Earnings Summary: Highlights of IDEXX’s Q4 2024 report - AlphaStreet
Idexx (IDXX) Reports Q4 Earnings: What Key Metrics Have to Say - Yahoo Finance
IDEXX Laboratories, Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2024 - Marketscreener.com
Q4 2024 IDEXX Laboratories Inc Earnings Call Transcript - GuruFocus.com
IDEXX Laboratories (NASDAQ:IDXX) Releases Quarterly Earnings Results, Beats Estimates By $0.23 EPS - MarketBeat
Idexx Laboratories Inc Stock (IDXX) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.18%
2.55%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):